Informazione:
Errore:
ID
28971
Descrizione
Study part: Study Drug Administration Month 3. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
versioni (1)
- 18/02/18 18/02/18 -
Titolare del copyright
Roche
Caricato su
18 febbraio 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Study Drug Administration Month 3 rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Study Drug Administration Month 3
- StudyEvent: ODM
Similar models
Study Drug Administration Month 3
- StudyEvent: ODM
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Therapy
Item
Was treatment (rhuFab V2 or sham procedure) administered?
boolean
C0087111 (UMLS CUI [1])
identification number
Item
If Yes, Record kit # administered:
text
C1300638 (UMLS CUI [1])
Date Administered
Item
Date Administered:
date
C0011008 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,2])
Time Administered
Item
Time Administered:
time
C0040223 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,2])
Drug Administration lidocaine
Item
Was lidocaine injection administered?
boolean
C3469597 (UMLS CUI [1,1])
C0023660 (UMLS CUI [1,2])
C0023660 (UMLS CUI [1,2])
preoperative antimicrobials
Item
Were preoperative antimicrobials given?
boolean
C2114165 (UMLS CUI [1])
drug dosage
Item
If No, Was treatment held due to any of the Study Drug Dose-Holding Criteria?
boolean
C0870450 (UMLS CUI [1])
Item
If Yes, check the corresponding event(s) for holding treatment:
text
C0087111 (UMLS CUI [1])
CL Item
Intraocular inflammation (Intraocular inflammation)
C0497211 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Visual acuity loss (Visual acuity loss)
C1836949 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Intraocular pressure (IOP) (Intraocular pressure (IOP))
C0578862 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Vitreous hemorrhage (Vitreous hemorrhage)
C0042909 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Sensory rhegmatogenous retinal break or detachment (Sensory rhegmatogenous retinal break or detachment)
C0035305 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Subfoveal hemorrhage (Subfoveal hemorrhage)
C0442185 (UMLS CUI-1)
C0019080 (UMLS CUI-2)
(Comment:en)
C0019080 (UMLS CUI-2)
(Comment:en)
CL Item
Local or systemic infection (Local or systemic infection)
C0009450 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Intraocular surgery (Intraocular surgery)
C0038894 (UMLS CUI-1)
C3282905 (UMLS CUI-2)
(Comment:en)
C3282905 (UMLS CUI-2)
(Comment:en)